Fujian Wanchen Biotechnology Co. Ltd (300972) — Tangible Net Worth Ratio
Fujian Wanchen Biotechnology Co. Ltd (300972) has a Tangible Net Worth Ratio of 95.7% as of March 2026. This metric is calculated by deducting intangible assets (CN¥145.94 Million) from net assets (CN¥3.42 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See 300972 book value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Fujian Wanchen Biotechnology Co. Ltd Tangible Net Worth Ratio (2019–2025)
This chart shows how Fujian Wanchen Biotechnology Co. Ltd's Tangible Net Worth Ratio has changed across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 95.7%, reflecting net assets of CN¥3.42 Billion with intangible assets of CN¥145.94 Million CNY. Also explore Fujian Wanchen Biotechnology Co. Ltd (300972) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Fujian Wanchen Biotechnology Co. Ltd (2019–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Fujian Wanchen Biotechnology Co. Ltd from 2019 to 2025, covering 7 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 300972 stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 96.8% | CN¥2.55 Billion | CN¥80.97 Million | CN¥10.05 Billion | ▲ +0.9 pp |
| 2024 | 95.9% | CN¥1.46 Billion | CN¥59.52 Million | CN¥7.25 Billion | ▲ +4.6 pp |
| 2023 | 91.3% | CN¥695.81 Million | CN¥60.59 Million | CN¥3.93 Billion | ▼ -0.8 pp |
| 2022 | 92.1% | CN¥672.36 Million | CN¥53.04 Million | CN¥1.20 Billion | ▲ +0.3 pp |
| 2021 | 91.8% | CN¥652.71 Million | CN¥53.41 Million | CN¥863.18 Million | ▲ +5.5 pp |
| 2020 | 86.3% | CN¥400.65 Million | CN¥54.82 Million | CN¥658.59 Million | ▲ +2.6 pp |
| 2019 | 83.7% | CN¥344.82 Million | CN¥56.19 Million | CN¥655.63 Million | — |